全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

sST2、IL-33在维持性血液透析患者血管钙化中的表达研究
Study on Expression of sST2 and IL-33 in Vascular Calcification of Maintenance Hemodialysis Patients

DOI: 10.12677/MD.2023.131003, PP. 13-19

Keywords: 维持性血液透析,血管钙化,可溶性ST2,白介素-33;Maintenance Hemodialysis, Vascular Calcification, Soluble ST2, Interleukin-33

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨维持性血液透析患者血清可溶性ST2 (sST2)、白介素-33 (IL-33)表达水平与血管钙化的关系。方法:选取2018年1月~2020年7月本院收治的150维持性血液透析患者为研究对象,根据钙化评分将维持性血液透析患者分为无钙化组60例、轻度钙化组51例、重度钙化组39例。采用酶联免疫吸附(ELISA)法检测血清sST2、IL-33、甲状旁腺激素(PTH)水平;采用全自动生化分析仪检测血清生化指标钙、磷、镁、白蛋白(Alb)水平;分析维持性血液透析血管钙化患者血清sST2、IL-33与钙化评分及生化指标的相关性;分析影响维持性血液透析患者血管钙化的因素。结果:重度钙化组sST2、IL-33、钙化评分、磷、钙磷乘积、PTH水平高于轻度钙化组和无钙化组,镁、Alb水平低于轻度钙化组和无钙化组(P < 0.05);轻度钙化组sST2、IL-33、钙化评分、磷、钙磷乘积、PTH水平高于无钙化组,镁、Alb水平低于无钙化组(P < 0.05)。维持性血液透析血管钙化患者血清sST2与IL-33呈正相关(r = 0.385;P < 0.05);维持性血液透析血管钙化患者血清sST2、IL-33与磷、钙磷乘积、PTH、钙化评分呈正相关,与镁、Alb呈负相关(P < 0.05)。sST2、IL-33是影响维持性血液透析患者血管钙化的独立危险因素(P < 0.05),Alb是影响维持性血液透析患者血管钙化的保护因素(P < 0.05)。结论:随着维持性血液透析患者血管钙化加重,血清sST2、IL-33表达水平呈升高趋势,二者与钙化评分呈正相关,可能对评估患者血管钙化严重程度有重要意义。
Objective: To investigate the relationship between serum soluble ST2 (sST2), interleukin-33 (IL-33) expression levels and vascular calcification in maintenance hemodialysis patients. Methods: From January 2018 to July 2020, 150 patients with maintenance hemodialysis in our hospital were se-lected as the research objects. According to the calcification score, the patients were divided into non calcification group (60 cases), mild calcification group (51 cases) and severe calcification group (39 cases). The levels of serum sST2, IL-33 and parathyroid hormone (PTH) were detected by en-zyme-linked immunosorbent assay (ELISA); the levels of serum calcium, phosphorus, magnesium and Albumin (Alb) were detected by automatic biochemical analyzer; the correlation of serum sST2 and IL-33 with calcification score and biochemical indexes was analyzed; the influencing factors of vascular calcification in maintenance hemodialysis patients were analyzed. Results: The levels of sST2, IL-33, calcification score, phosphorus, calcium phosphorus product and PTH in severe calcifi-cation group were higher than those in mild calcification group and non calcification group, while the levels of magnesium and Alb were lower than those in mild calcification group and non calcifica-tion group (P < 0.05); the levels of sST2, IL-33, calcification score, phosphorus, calcium phosphorus product and PTH in mild calcification group were higher than those in non calcification group, while the levels of magnesium and Alb were lower than those in non calcification group (P < 0.05). There was a positive correlation between serum sST2 and IL-33 in maintenance hemodialysis patients with vascular calcification (r = 0.385; P < 0.05); serum sST2 and IL-33 were positively correlated with phosphorus, calcium phosphorus product, PTH and calcification score, but negatively

References

[1]  Fayed, A., Soliman, A., Mahdy, H.E., et al. (2020) Impact of Hepatitis Virus Infection on Arterial Calcification among Incident Hemodialysis Patients. Nefrologia, 40, 336-344.
https://doi.org/10.1016/j.nefro.2019.09.005
[2]  邹杨, 洪大情, 夏菊花, 等. 老年维持性血液透析患者心血管钙化危险因素分析[J]. 心肺血管病杂志, 2019, 38(1): 64-68.
[3]  汤丰宁, 龙勇, 丁宁, 等. sST2、IL-33与慢性肾衰竭患者心力衰竭的相关性研究[J]. 中国医学前沿杂志(电子版), 2019, 11(4): 44-48.
[4]  张永敏. 血清sST2, IL-33水平在CRF患者心功能不全诊断中的临床价值[J]. 承德医学院学报, 2019, 36(6): 509-511.
[5]  Adragao, T., Ferreira, A., Frazao, J.M., et al. (2017) Higher Mineralized Bone Volume Is Associated with a Lower Plain X-Ray Vascular Calcification Score in Hemodialysis Patients. PLOS ONE, 12, e0179868.
https://doi.org/10.1371/journal.pone.0179868
[6]  刘莉, 叶鹏, Nicoll R, 等. 在有症状的患者中, 与传统危险因素相比, 冠状动脉钙化积分能更准确地预测显著的冠状动脉狭窄: 欧洲钙化性冠状动脉疾病研究[J]. 中华高血压杂志, 2016, 24(3): 206.
[7]  Choi, S.R., Lee, Y.K., Cho, A.J., et al. (2019) Malnutrition, Inflammation, Progression of Vascular Cal-cification and Survival: Inter-Relationships in Hemodialysis Patients. PLOS ONE, 14, e0216415.
https://doi.org/10.1371/journal.pone.0216415
[8]  王亚萍. 血管钙化相关MicroRNA的研究进展[J]. 心血管病学进展, 2018, 39(4): 643-647.
[9]  Lee, C.T., Lee, Y.T., Tain, Y.L., et al. (2019) Circulating microRNAs and Vascular Calcifica-tion in Hemodialysis Patients. Journal of International Medical Research, 47, 2929-2939.
https://doi.org/10.1177/0300060519848949
[10]  Raffaele, A., Rana, G., Ziad, M., et al. (2018) Conflicting Vascular and Metabolic Impact of the il-33/sst2 Axis. Cardiovascular Research, 114, 1578-1594.
https://doi.org/10.1093/cvr/cvy166
[11]  杨瑞波, 信栓力. 可溶性ST2在急性心肌梗死中的研究进展[J]. 临床心血管病杂志, 2018, 34(2): 202-206.
[12]  徐力, 杨定平, 陈文莉, 等. 瑞舒伐他汀对血液透析患者心功能及血清可溶性ST2和Galectin-3浓度影响[J]. 临床肾脏病杂志, 2019, 19(12): 883-886.
[13]  何剑, 秦凯炜. 血清sST2蛋白与维持性血液透析患者心血管疾病及总体预后的相关性分析[J]. 解放军医药杂志, 2018, 30(9): 48-52.
[14]  Ulutas, O., Taskapan, M.C., Dogan, A., et al. (2018) Vascular Calcification Is Not Related to Serum Fetuin-A and Osteopontin Levels in Hemodialysis Pa-tients. International Urology and Nephrology, 50, 137-142.
https://doi.org/10.1007/s11255-017-1740-6
[15]  李大勇, 袁新科, 刘冠兰, 等. 维持性血液透析患者血清Irisin, BMP-7水平与血管钙化及钙磷代谢指标的相关性研究[J]. 中国现代医学杂志, 2019, 29(15): 41-46.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133